ADX-850

N/A

Report date: 2025/04/08 10:17:57
NME

Base Information

Drug NameADX-850
Drug Alias NameADX-850
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceAngiotensinogen inhibitors
TargetsAngiotensinogen
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesADARx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesADARx Australia Pty LtdADARx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A